Skip to content

Author

Carlos Roberto Koscky Paier

Physiology and Pharmacology Department

We have 3 of 28 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Photoredox and PIFA-mediated synthesis of N-aryl azacoumestanes: Antileukemic activity and venetoclax synergism in acute myeloid leukemia.

N-Aryl azacoumestanes, nitrogen-bridged analogs of natural coumestanes, represent a structurally appealing yet underexplored scaffold in medicinal chemistry. Here, we describe a concise three-step synthesis of these derivatives from 4-hydroxycoumarin and anilines, combining a visible-light [Ru(bpy)₃]Cl₂-mediated photor...

Rachel C. V. Novas, J. de Brito V., M. T. D. de Carvalho et al. · 0 citations
Oct 2026

Organoselenium-containing monastrol analogs show preferential antileukemic activity and distinct cellular responses consistent with kinesin Eg5 engagement.

Selenium-containing dihydropyrimidinones (DHPMs) have emerged as promising scaffolds for anticancer drug development owing to their structural versatility and ability to modulate biologically relevant targets. Here, we investigated the antileukemic activity of two previously reported selenium-containing monastrol analo...

D. N. Costa, Thais L. Brito, Fátima de Cássia E. de Oliveira et al. · 0 citations
Open access Aug 2026

Prodrug-like Quinone Containing Two Redox-Active Centers Induces Ferroptosis in Prostate Cancer Cells with Cytotoxic Action Partially Depending on NAD(P)H Quinone Dehydrogenase 1 (NQO1)

Overall, compound 4 highlights the potential of dual-redox quinone platforms to induce ferroptosis, providing a viable lead candidate for novel antineoplastic drug discovery in prostate cancer and other malignancies.

E. N. Mendoza, Maria Fernanda Madrid, P. M. D. da Costa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.